Literature DB >> 18165001

Hypothyroidism following partial thyroidectomy.

Michael Vaiman1, Andrey Nagibin, Philippe Hagag, Alex Kessler, Haim Gavriel.   

Abstract

OBJECTIVE: To compare rates of hypothyroidism following three types of partial thyroidectomy for multinodular goiter. STUDY DESIGN AND METHODS: All cases of partial thyroidectomies (hemi-, near-total, or subtotal) carried out at one Israeli and one Russian medical center (1990-2006) were retrospectively studied to determine the incidence of hypothyroidism after each procedure.
RESULTS: There were 881 near-total, 1538 subtotal, and 1051 hemithyroidectomies (total 3470). Postoperative follow-up was 2 to 15 years. Twenty-eight percent of the hemithyroidectomy patients suffered permanent hypothyroidism compared to 100% of the near-total and 87% of the subtotal patients. Forty-six percent of the hemithyroidectomy patients suffered temporary hypothyroidism compared to 100% of the near-total and 93% of the subtotal patients.
CONCLUSION: Subtotal and near-total thyroidectomies produced a rate of hypothyroidism close to that of total thyroidectomy compared to 28% after hemithyroidectomy. SIGNIFICANCE: Partial thyroidectomies provide no decisive advantage over total thyroidectomies in terms of subsequent requirements of supplemental hormone therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18165001     DOI: 10.1016/j.otohns.2007.09.015

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  15 in total

1.  Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules.

Authors:  Xiao-Long Li; Hui-Xiong Xu; Feng Lu; Wen-Wen Yue; Li-Ping Sun; Xiao-Wan Bo; Le-Hang Guo; Jun-Mei Xu; Bo-Ji Liu; Dan-Dan Li; Shen Qu
Journal:  Br J Radiol       Date:  2016-01-22       Impact factor: 3.039

2.  Complications in primary and completed thyroidectomy.

Authors:  Michael Vaiman; Andrey Nagibin; Julian Olevson
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

3.  Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis.

Authors:  Zhe Li; Yuxuan Qiu; Yuan Fei; Zhichao Xing; Jingqiang Zhu; Anping Su
Journal:  Endocrine       Date:  2020-07-07       Impact factor: 3.633

4.  Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance.

Authors:  Courtney J Balentine; David J Vanness; David F Schneider
Journal:  Surgery       Date:  2017-11-08       Impact factor: 3.982

Review 5.  Hormone replacement after thyroid and parathyroid surgery.

Authors:  Andreas Schäffler
Journal:  Dtsch Arztebl Int       Date:  2010-11-26       Impact factor: 5.594

6.  Radiofrequency ablation of benign symptomatic thyroid nodules: prospective safety and efficacy study.

Authors:  M Umit Ugurlu; Kivilcim Uprak; Ihsan N Akpinar; Wafi Attaallah; Cumhur Yegen; Bahadir M Gulluoglu
Journal:  World J Surg       Date:  2015-04       Impact factor: 3.352

7.  Thyroid hormone replacement after thyroid lobectomy.

Authors:  Samantha J Stoll; Susan C Pitt; Jing Liu; Sarah Schaefer; Rebecca S Sippel; Herbert Chen
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982

8.  Hypothyroidism after hemithyroidectomy.

Authors:  Meena Said; Vicki Chiu; Philip I Haigh
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

9.  Hypothyroidism, new nodule formation and increase in nodule size in patients who have undergone hemithyroidectomy.

Authors:  Sibel Ertek; Reyhan Ünlü Ersoy; Cüneyd Anıl; Ozgür Demir; Murat Faik Erdoğan; Sevim Güllü; Dilek Berker; Kamile Gül; Uğur Unlütürk; Gürbüz Erdoğan
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

10.  Long-Term Results of Ultrasound-Guided Radiofrequency Ablation of Benign Thyroid Nodules: State of the Art and Future Perspectives-A Systematic Review.

Authors:  Hervé Monpeyssen; Ahmad Alamri; Adrien Ben Hamou
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-26       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.